Spr Chemopharma Private Limited
Chemical manufacturing company based in Maharashtra, established in 2018.
2018 | Raigarh, Maharashtra (India) | Active
Spr Chemopharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.15 Cr
- Revenue Growth 92.60%
- Profit Growth 165.76%
- Ebitda 162.99%
- Net Worth 115.17%
- Total Assets 81.52%
About Spr Chemopharma
Spr Chemopharma Private Limited (SCPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 April 2018 (Six years and ten months 28 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.15 Cr.
Premprasad Verma and Arun Verma serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304MH2018PTC307357
- Company No.
307357
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2018
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Chemicals and Materials
Who are the key members and board of directors at Spr Chemopharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Premprasad Verma  | Director | 02-Apr-2018 | Current |
| Arun Verma | Director | 02-Apr-2018 | Current |
Financial Performance of Spr Chemopharma.
Spr Chemopharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 92.6% increase. The company also saw a substantial improvement in profitability, with a 165.76% increase in profit. The company's net worth Soared by an impressive increase of 115.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spr Chemopharma?
Unlock access to Spr Chemopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹21.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
- Hdfc Bank Limited : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2023 | Hdfc Bank Limited | ₹1.50 M | Open |
| 21 Jan 2023 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Spr Chemopharma?
Unlock and access historical data on people associated with Spr Chemopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spr Chemopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spr Chemopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.